Buscar
Metagenomi Inc
MGXAñadir a la lista de seguimiento
1.260USD
+0.050+4.13%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
47.44MCap. mercado
PérdidaP/E TTM
Más Datos de Metagenomi Inc Compañía
Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.
Información de Metagenomi Inc
Símbolo de cotizaciónMGX
Nombre de la empresaMetagenomi Inc
Fecha de salida a bolsaFeb 09, 2024
Director ejecutivoIrish (Jian)
Número de empleados202
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 09
Dirección5959 Horton St
CiudadEMERYVILLE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94608
Teléfono15108714880
Sitio Webhttps://metagenomi.co/
Símbolo de cotizaciónMGX
Fecha de salida a bolsaFeb 09, 2024
Director ejecutivoIrish (Jian)
Ejecutivos de Metagenomi Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.40M
+1.61%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
600.86K
-0.62%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.40M
+1.61%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
600.86K
-0.62%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Metagenomi Inc?
Los cinco principales accionistas de Metagenomi Inc son: Dr. Brian C. Thomas, Ph.D.
¿Cuántas instituciones poseen acciones de Metagenomi Inc (MGX)?
A fecha de 2026Q1, 172 instituciones poseen acciones de Metagenomi Inc, con un valor de mercado combinado de aproximadamente 8.82M, lo que representa el 23.43% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -6411264.00.